Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity

Annals of Clinical and Translational Neurology

Volumn 1, Issue 8, 2014, Pages 589-604

  Choi, Joungil ^a,b   Chandrasekaran, Krish ^a,b   Demarest, Tyler G ^a   Kristian, Tibor ^a,b   Xu, Su ^c   Vijaykumar, Kadambari ^a,b   Dsouza, Kevin Geoffrey ^a,b   Qi, Nathan R ^d   Yarowsky, Paul J ^a   Gallipoli, Rao ^c   Koch, Lauren G ^d   Fiskum, Gary M ^a   Britton, Steven L ^d   Russell, James W ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CHAPERONIN 60; CHOLESTEROL; CHOLINE DERIVATIVE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; GRP 75 PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTONE H3; INOSITOL; INSULIN; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL TRANSCRIPTION FACTOR A; N ACETYLASPARTIC ACID; NDUFV2 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1; TAU PROTEIN; TAURINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AEROBIC CAPACITY; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY TEMPERATURE; BODY WEIGHT; BRAIN FUNCTION; BREATHING RATE; CELL COUNT; COGNITIVE DEFECT; COLORIMETRY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIFFUSION WEIGHTED IMAGING; DNA DAMAGE; GENE DOSAGE; HIPPOCAMPUS; IMAGING; IMMUNOELECTRON MICROSCOPY; MALE; MITOCHONDRIAL RESPIRATION; MOTOR ACTIVITY; NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS; NERVE DEGENERATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RESPIRATORY QUOTIENT; RUNNING; STEREOLOGY; TRANSMISSION ELECTRON MICROSCOPY; TREADMILL TEST; WESTERN BLOTTING; Y-MAZE TEST;

EID: 84982820870     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.86     Document Type: Article

References (73)

1. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007;29:1–5.
2. Strachan MW, Price JF, Frier BM. Diabetes, cognitive impairment, and dementia. BMJ 2008;336:6.
3. Cole AR, Astell A, Green C, et al. Molecular connexions between dementia and diabetes. Neurosci Biobehav Rev 2007;31:1046–1063.
4. Grunblatt E, Bartl J, Riederer P. The link between iron, metabolic syndrome, and Alzheimer's disease. J Neural Transm 2011;118:371–379.
5. Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999;53:1937–1942.
6. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med 2013;369:540–548.
7. Koch LG, Britton SL. Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol Genomics 2001;5:45–52.
8. Wisloff U, Najjar SM, Ellingsen O, et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 2005;307:418–420.
9. Koch LG, Britton SL, Wisloff U. A rat model system to study complex disease risks, fitness, aging, and longevity. Trends Cardiovasc Med 2013;22:29–34.
10. Valla J, Schneider L, Niedzielko T, et al. Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 2006;6:323–330.
11. Moreira PI, Santos MS, Seica R, et al. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes. J Neurol Sci 2007;257:206–214.
12. Johnson GV, Stoothoff WH. Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 2004;117:5721–5729.
13. Li L, Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 2007;56:384–402.
14. Miklossy J, Qing H, Radenovic A, et al. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging 2010;31:1503–1515.
15. Sivitz WI, Yorek MA. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 2010;12:537–577.
16. Gibson GE, Starkov A, Blass JP, et al. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 2010;1802:122–134.
17. Hinder LM, Vivekanandan-Giri A, McLean LL, et al. Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. J Endocrinol 2013;216:1–11.
18. Bosetti F, Brizzi F, Barogi S, et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 2002;23:371–376.
19. Olsson AH, Yang BT, Hall E, et al. Decreased expression of genes involved in oxidative phosphorylation in human pancreatic islets from patients with type 2 diabetes. Eur J Endocrinol 2011;165:589–595.
20. Soyal SM, Felder TK, Auer S, et al. Greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Hum Mol Genet 2012;21:3461–3473.
21. Johri A, Starkov AA, Chandra A, et al. Truncated peroxisome proliferator-activated receptor-gamma coactivator 1alpha splice variant is severely altered in Huntington's disease. Neurodegener Dis 2011;8:496–503.
22. Lin J, Wu PH, Tarr PT, et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004;119:121–135.
23. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267–273.
24. St-Pierre J, Drori S, Uldry M, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006;127:397–408.
25. Choi J, Batchu VV, Schubert M, et al. A novel PGC-1alpha isoform in brain localizes to mitochondria and associates with PINK1 and VDAC. Biochem Biophys Res Commun 2013;435:671–677.
26. Ekstrand MI, Falkenberg M, Rantanen A, et al. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet 2004;13:935–944.
27. Silva JP, Kohler M, Graff C, et al. Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet 2000;26:336–340.
28. Wang R, Li JJ, Diao S, et al. Metabolic stress modulates Alzheimer's beta-secretase gene transcription via SIRT1-PPARgamma-PGC-1 in neurons. Cell Metab 2013;17:685–694.
29. Khan RS, Fonseca-Kelly Z, Callinan C, et al. SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Front Cell Neurosci 2012;6:63.
30. Jiang M, Wang J, Fu J, et al. Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med 2011;18:153–158.
31. Vidoni ED, Van Sciver A, Johnson DK, et al. A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease. Contemp Clin Trials 2012;33:1105–1116.
32. Yu F, Thomas W, Nelson NW, et al. Impact of 6-month aerobic exercise on Alzheimer's symptoms. J Appl Gerontol. 201x;xx:1–17.
33. Frahm J, Haase A, Matthaei D. Rapid three-dimensional MR imaging using the FLASH technique. J Comput Assist Tomogr 1986;10:363–368.
34. Haase A, Frahm J, Matthaei D, et al. MR imaging using stimulated echoes (STEAM). Radiology 1986;160:787–790.
35. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 1993;29:804–811.
36. Hennig J, Nauerth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Reson Med 1986;3:823–833.
37. Price WS, Arata Y. The manipulation of water relaxation and water suppression in biological systems using the water-PRESS pulse sequence. J Magn Reson B 1996;112:190–192.
38. Paxinos G, Watson C. The mouse brain in stereotaxic coordinates. 6th ed. New York: Academic Press, 2007.
39. Wolf OT, Dyakin V, Vadasz C, et al. Volumetric measurement of the hippocampus, the anterior cingulate cortex, and the retrosplenial granular cortex of the rat using structural MRI. Brain research. Brain Res Brain Res Protoc 2002;10:41–46.
40. Bogaert YE, Sheu KF, Hof PR, et al. Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation. Exp Neurol 2000;161:115–126.
41. Wittig I, Karas M, Schagger H. High resolution clear native electrophoresis for in-gel functional assays and fluorescence studies of membrane protein complexes. Mol Cell Proteomics 2000;6:1215–1225.
42. Marjanska M, Curran GL, Wengenack TM, et al. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 2005;102:11906–11910.
43. Xu S, Zhuo J, Racz J, et al. Early microstructural and metabolic changes following controlled cortical impact injury in rat: a magnetic resonance imaging and spectroscopy study. J Neurotrauma 2011;28:2091–2102.
44. 1H spectra with LCModel. NMR Biomed 2001;14:260–264.
45. Ke YD, Delerue F, Gladbach A, et al. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 2009;4:e7917.
46. 2 emission capacities without major shifts in myosin heavy chain isoform. J Appl Physiol 1985;2012:1624–1634.
47. Thyfault JP, Rector RS, Uptergrove GM, et al. Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury. J Physiol 2009;587:1805–1816.
48. Sapolsky RM. Cellular defenses against excitotoxic insults. J Neurochem 2001;76:1601–1611.
49. Mark LP, Prost RW, Ulmer JL, et al. Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. Am J Neuroradiol 2001;22:1813–1824.
50. Yoshiyama Y, Higuchi M, Zhang B, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007;53:337–351.
51. Paula-Lima AC, De Felice FG, Brito-Moreira J, et al. Activation of GABA receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 2005;49:1140–1148.
52. Wu H, Jin Y, Wei J, et al. Mode of action of taurine as a neuroprotector. Brain Res 2005;1038:123–131.
53. Santa-Maria I, Hernandez F, Moreno FJ, et al. Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation. Neurosci Lett 2007;429:91–94.
54. Thurston JH, Sherman WR, Hauhart RE, et al. Myo-inositol: a newly identified nonnitrogenous osmoregulatory molecule in mammalian brain. Pediatr Res 1989;26:482–485.
55. Ripps H, Shen W. Review: taurine: a “very essential” amino acid. Mol Vis 2012;18:2673–2686.
56. Du AT, Schuff N, Amend D, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001;71:441–447.
57. Walter A, Korth U, Hilgert M, et al. Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging 2004;25:1299–1303.
58. Farber SA, Slack BE, Blusztajn JK. Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease. FASEB J 2000;14:2198–2206.
59. Kerchner GA, Hess CP, Hammond-Rosenbluth KE, et al. Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology 2010;75:1381–1387.
60. Hoxworth JM, Xu K, Zhou Y, et al. Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation. Brain Res 1999;821:467–479.
61. Churchwell JC, Morris AM, Musso ND, et al. Prefrontal and hippocampal contributions to encoding and retrieval of spatial memory. Neurobiol Learn Mem 2010;93:415–421.
62. Wikgren J, Mertikas GG, Raussi P, et al. Selective breeding for endurance running capacity affects cognitive but not motor learning in rats. Physiol Behav 2012;106:95–100.
63. Tweedie C, Romestaing C, Burelle Y, et al. Lower oxidative DNA damage despite greater ROS production in muscles from rats selectively bred for high running capacity. Am J Physiol Regul Integr Comp Physiol 2011;300:R544–R553.
64. Aquilano K, Baldell S, Pagliei B, et al. Extranuclear localization of SIRT1 and PGC-1alpha: an insight into possible roles in diseases associated with mitochondrial dysfunction. Curr Mol Med 2013;13:140–154.
65. Aquilano K, Vigilanza P, Baldelli S, et al. Peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem 2010;285:21590–21599.
66. Chen J, Zhou Y, Mueller-Steiner S, et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 2005;280:40364–40374.
67. Ramadori G, Lee CE, Bookout AL, et al. Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci 2005;28:9989–9996.
68. Biason-Lauber A, Boni-Schnetzler M, Hubbard BP, et al. Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell Metab 2013;17:448–455.
69. Kilbride SM, Gluchowska SA, Telford JE, et al. High-level inhibition of mitochondrial complexes III and IV is required to increase glutamate release from the nerve terminal. Mol Neurodegener 2011;6:53.
70. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 2005;32:486–510.
71. Ramsden M, Kotilinek L, Forster C, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 2005;25:10637–10647.
72. Melov S, Adlard PA, Morten K, et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2007;20:e536.
73. Santacruz K, Lewis J, Spires T, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005;309:476–481.